Investigating the Risk Factors Affecting the Survival Rate of Breast Cancer Patients Using Cured Model Based on Defective Distribution.

Background: The analysis methods for breast cancer (BC) data have also advanced alongside medical advancements in the treatment of the disease. Objectives: This study tried to investigate the factors affecting the survival rate of BC patients using the cured model based on Kumaraswamy's defective di...

Descripción completa

Detalles Bibliográficos
Publicado en:International Journal of Cancer Management Vol. 17; no. 1; pp. 1 - 11
Autores principales: Taheri, Seyede Solmaz, Akbari, Mohammad Esmaeil, Khadem Maboudi, Ali Akbar, Baghestani, Ahmadreza
Formato: equations & formulas research tables/charts Journal Article
Publicado: Medical Journals Commission of the Ministry of Health & Medical Education Dec2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=182175705&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 182175705
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        25384422
        L6AI
      jtl: International Journal of Cancer Management
      issn: 25384422
      maglogo: N
    pubinfo:
      dt: Dec2024
      vid: 17
      iid: 1
      pid: 66482
      pub: Medical Journals Commission of the Ministry of Health & Medical Education
    artinfo:
      ui:
        182175705
        182175705
        182175705
        10.5812/ijcm-139947
        182175705
      ppf: 1
      ppct: 10
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Investigating the Risk Factors Affecting the Survival Rate of Breast Cancer Patients Using Cured Model Based on Defective Distribution.
      aug:
        au:
          Taheri, Seyede Solmaz
          Akbari, Mohammad Esmaeil
          Khadem Maboudi, Ali Akbar
          Baghestani, Ahmadreza
        affil: Department of Biostatistics, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
      sug:
        subj:
          Breast Neoplasms Mortality
          Breast Neoplasms Prognosis
          Mortality Risk Factors
          Risk Assessment
          Women's Health
          Human
          Female
          Middle Age
          Aged
          Aged, 80 and Over
          Cancer Patients
          Iran
          Retrospective Design
          Record Review
          Prediction Models
          Age Factors
          Neoplasm Staging
          Tumor Burden
          Hormone Therapy
          Survival Analysis
          Survival Rate
          Middle Aged: 45-64 years
          Aged: 65+ years
          Aged, 80 & over
          Female
      ab: Background: The analysis methods for breast cancer (BC) data have also advanced alongside medical advancements in the treatment of the disease. Objectives: This study tried to investigate the factors affecting the survival rate of BC patients using the cured model based on Kumaraswamy's defective distribution. Methods: A retrospective study collected data on 2 574 BC patients between September 2013 and September 2020, including demographic, clinicopathological, and biological characteristics. The best model for predicting cure was chosen based on AIC. Results: The selected cure model revealed that age (P = 0.046), tumor histologic grade (P = 0.0.38), tumor size (P = 0.0.41), HER2 status (P = 0.001), KI67 levels (P = 0.027), P53 status (P = 0.029), and hormone therapy (P = 0.039) were significant variables. The estimated cured rate of this data was 0.82. Conclusions: Considering that the advanced cured model has the highest accuracy in identifying the factors affecting the survival rate of BC patients and more risk factors have become significant in this model, it is recommended to pay special attention to patients aged over 60 with poorly differentiated historical grade, T3 tumor size, HER2 positive status, KI67 levels below 20%, negative P53 status, and no hormone therapy received in the process of disease prognosis.
      pubtype: Academic Journal
      doctype:
        equations & formulas
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N